Clinical Trials Logo

Motor Tic Disorder clinical trials

View clinical trials related to Motor Tic Disorder.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT03625453 Completed - Tourette Syndrome Clinical Trials

Study of ABX-1431 in Adult Patients With Tourette Syndrome or Chronic Motor Tic Disorder

Start date: October 15, 2018
Phase: Phase 2
Study type: Interventional

Two-part study consisting of a double-blind, randomized, placebo-controlled, study at two target dose levels (Part 1) and an open-label, non-randomized study (Part 2) to determine the efficacy of ABX-1431 in treating adult patients with Tourette syndrome or Chronic Motor Tic Disorder as measured by the change from baseline in Total Tic Score of the Yale Global Tic Severity Scale (YGTSS-TTS) compared with placebo.